| Financial Year |
March 31 2023 |
| Monetary Funds |
2,288,034,853.60 |
| Held-for-trading Financial Assets |
1,821,638,471.47 |
| Notes Receivable |
-- |
| Accounts Receivable |
642,508,393.37 |
| Advances to Suppliers |
229,191,569.83 |
| Other Receivables |
16,509,363.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
759,095,149.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
412,075,458.77 |
| Total Current Assets |
6,796,828,000.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,040,913.14 |
| Investment Properties |
-- |
| Fixed Assetes |
2,680,803,521.97 |
| Under-construction Projects |
196,103,783.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
263,627,098.04 |
| R&D expenses |
-- |
| Goodwill |
1,806,108.45 |
| Long-Term Deferred and Prepaid Expenses |
23,528,085.94 |
| Deferred Income Tax Assets |
11,847,175.23 |
| Other Non-Current Assets |
317,576,975.45 |
| Sub-Total of Non-Current Assets |
3,914,737,849.53 |
| Total Assets |
10,711,565,850.16 |
| Short-Term Loans |
450,366,164.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
439,252,379.77 |
| Accounts Payable |
641,577,897.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
131,925,730.83 |
| Taxes Payable |
134,718,234.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,280,071.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
802,361,784.62 |
| Other Current Liabilities |
76,117,476.92 |
| Sub-Total of Current Liabilities |
2,813,924,202.32 |
| Long-term Loans |
484,998,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,150,135.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
643,498,163.89 |
| Total Liabilities |
3,457,422,366.21 |
| Paid-In Capital(Or Share Stock) |
560,919,193.00 |
| Capital Surplus |
380,756,930.51 |
| Surplus Reserve |
358,648,008.88 |
| LESS:Treasury Stock |
173,527,678.11 |
| Undistributed Profits |
5,961,595,754.65 |
| Minority Stockholder's Interest |
2,001,370.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,252,142,113.48 |
| Owner's Equity（Stockholder's Equity） |
7,254,143,483.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,711,565,850.16 |
